GSK to Close Ermington plant in Australia by 2020

GSK plans to shutter its over-the-counter consumer healthcare manufacturing facility in Ermington, Australia, by 2020 which will affect about 223 jobs.

The closure of the Ermington plant isn’t expected to impact other GSK operations in the country, which include the manufacturing site in Boronia that produces respiratory products.

“We have thoroughly evaluated a number of options before taking the decision to close the site, but unfortunately significant ongoing investment would be needed to maintain our Ermington manufacturing facility, making it uncompetitive to keep manufacturing in Ermington in the future,” the company said.